GLP-1 receptor agonists as promising disease-modifying agents in WFS1 spectrum disorder

WFS1 spectrum disorder (WFS1-SD) is a rare monogenic neurodegenerative disorder whose cardinal symptoms are childhood-onset diabetes mellitus, optic atrophy, deafness, diabetes insipidus, and neurological signs ranging from mild to severe. The prognosis is poor as most patients die prematurely with...

Descripción completa

Detalles Bibliográficos
Autores principales: Panfili, Eleonora, Frontino, Giulio, Pallotta, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Clinical Diabetes and Healthcare
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275359/
https://www.ncbi.nlm.nih.gov/pubmed/37333802
http://dx.doi.org/10.3389/fcdhc.2023.1171091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275359/
https://www.ncbi.nlm.nih.gov/pubmed/37333802
http://dx.doi.org/10.3389/fcdhc.2023.1171091

Ejemplares similares